MENU
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TG Therapeutics (TGTX) Ownership - Who owns TG Therapeutics?

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.33B
P/E Ratio
19.02
Total Cash
514.43M
Projected Growth
N/A
Total Debt
753.56M
Revenue
700.35M
Risk (Beta)
1.74
Dividend Yield
N/A
Total Cash/Share
3.36
Total Debt/Equity
0.21
Revenue/Share
4.36 USD as % of share price
View a ticker or compare two or three
TGTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com